Skip to main content
Log in

Decrease in TSH levels after lactose restriction in Hashimoto’s thyroiditis patients with lactose intolerance

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

We aimed to evaluate the prevalence of lactose intolerance (LI) in patients with Hashimoto’s thyroiditis (HT) and the effects of lactose restriction on thyroid function in these patients. Eighty-three HT patients taking l-thyroxine (LT4) were enrolled, and lactose tolerance tests were performed on all patients. Lactose intolerance was diagnosed in 75.9 % of the patients with HT. Thirty-eight patients with LI were started on a lactose-restricted diet for 8 weeks. Thirty-eight patients with LI (30 euthyroid and 8 with subclinical hypothyroidism), and 12 patients without LI were included in the final analysis. The level of TSH significantly decreased in the euthyroid and subclinical hypothyroid patients with LI [from 2.06 ± 1.02 to 1.51 ± 1.1 IU/mL and from 5.45 ± 0.74 to 2.25 ± 1.88 IU/mL, respectively (both P < 0.05)]. However, the level of TSH in patients without LI did not change significantly over the 8 weeks (P > 0.05). Lactose intolerance occurs at a high frequency in HT patients. Lactose restriction leads to decreased levels of TSH, and LI should be considered in hypothyroid patients who require increasing LT4 doses, have irregular TSH levels and are resistant to LT4 treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. M. Ruchała, E. Szczepanek-Parulska, A. Zybek, The influence of lactose intolerance and other gastro-intestinal tract disorders on L-thyroxine absorption. Endocrinol. Pol. 63, 318–323 (2012)

    Google Scholar 

  2. M. Centanni, Thyroxine treatment: absorption, malabsorption, and novel therapeutic approaches. Endocrine 43, 8–9 (2013)

    Article  CAS  PubMed  Google Scholar 

  3. E. Vermeire, H. Hearnshaw, P. Van Royen, J. Denekens, Patient adherence to treatment: three decades of research. A comprehensive review. J. Clin. Pharm. Ther. 26, 331–342 (2001)

    Article  CAS  PubMed  Google Scholar 

  4. T.G. Bach-Huynh, B. Nayak, J. Loh, S. Soldin, J. Jonklaas, Timing of levothyroxine administration affects serum thyrotropin concentration. J. Clin. Endocrinol. Metab. 94, 3905–3912 (2009)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. P. Colucci, C.S. Yue, M. Ducharme, S. Benvenga, A review of the pharmacokinetics of levothyroxine for the treatment of hypothyroidism. Eur. Endocrinol. 9, 40–47 (2013)

    Google Scholar 

  6. S. Benvenga, L. Bartolone, M.A. Pappalardo, A. Russo, D. Lapa, G. Giorgianni, G. Saraceno, F. Trimarchi, Altered intestinal absorption of l-thyroxine caused by coffee. Thyroid 18, 293–301 (2008)

    Article  CAS  PubMed  Google Scholar 

  7. J.J. Lilja, K. Laitinen, P.J. Neuvonen, Effects of grapefruit juice on the absorption of levothyroxine. Br. J. Clin. Pharmacol. 60, 337–341 (2005)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. L. Liwanpo, J.M. Hershman, Conditions and drugs interfering with thyroxine absorption. Best Pract. Res. Clin. Endocrinol. Metab. 23, 781–792 (2009)

    Article  CAS  PubMed  Google Scholar 

  9. C. Virili, G. Bassotti, M.G. Santaguida, R. Iuorio, S.C. Del Duca, V. Mercuri, A. Picarelli, P. Gargiulo, L. Gargano, M. Centanni, Atypical celiac disease as cause of increased need for thyroxine: a systematic study. J. Clin. Endocrinol. Metab. 97, 419–422 (2012)

    Article  Google Scholar 

  10. P. Puri, E.J. Guiney, Transient hypothyroidism associated with short gut syndrome. J. Pediatr. Surg. 17, 22–24 (1982)

    Article  CAS  PubMed  Google Scholar 

  11. M. Muñoz-Torres, M. Varsavsky, G. Alonso, Lactose intolerance revealed by severe resistance to treatment with levothyroxine. Thyroid 16, 1171–1173 (2006)

    Article  PubMed  Google Scholar 

  12. N.S. Scrimshaw, E.B. Murray, Prevalence of lactose maldigestion. Am. J. Clin. Nutr. 48, 1086–1098 (1988)

    Google Scholar 

  13. E. Tuncbilek, R. Türün, B. Say, Lactose intolerance in Turkey. Lancet 2, 151 (1973)

    Article  CAS  PubMed  Google Scholar 

  14. S.J. Mandel, G.A. Brent, P.R. Larsen, Levothyroxine therapy in patients with thyroid disease. Ann. Intern. Med. 119, 492–502 (1993)

    Article  CAS  PubMed  Google Scholar 

  15. S. Ladas, J. Papanikos, G. Arapakis, Lactose malabsorption in Greek adults: correlation of small bowel transit time with the severity of lactose intolerance. Gut 23, 968–973 (1982)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. H. Arola, Diagnosis of hypolactasia and lactose malabsorption. Scand. J. Gastroenterol. 29, 26–35 (1994)

    Article  Google Scholar 

  17. S.L. Carter, S. Attel, The diagnosis and management of patients with lactose-intolerance. Nurse Pract. 38, 23–28 (2013)

    Article  PubMed  Google Scholar 

  18. S. Reichlin, R.D. Utiger, Regulation of the pituitary-thyroid axis in man: relationship of TSH concentration to concentration of free and total thyroxine in plasma. J. Clin. Endocrinol. Metab. 27, 251–255 (1967)

    Article  CAS  PubMed  Google Scholar 

  19. M.B. Heyman, Lactose intolerance in infants, children, and adolescents. Pediatrics 118, 1279–1286 (2006)

    Article  PubMed  Google Scholar 

  20. C.L. Ch’ng, M.K. Jones, J.G. Kingham, Celiac disease and autoimmune thyroid disease. Clin. Med. Res. 5, 184–192 (2007)

    Article  PubMed Central  PubMed  Google Scholar 

  21. V. Ojetti, G. Nucera, A. Migneco, M. Gabrielli, C. Lauritano, S. Danese, M.A. Zocco, E.C. Nista, G. Cammarota, A. De Lorenzo, G. Gasbarrini, A. Gasbarrini, High prevalence of celiac disease in patients with lactose intolerance. Digestion 71, 106–110 (2005)

    Article  PubMed  Google Scholar 

  22. P. Eadala, J.P. Waud, S.B. Matthews, J.T. Green, A.K. Campbell, Quantifying the ‘hidden’ lactose in drugs used for the treatment of gastrointestinal conditions. Aliment. Pharmacol. Ther. 29, 677–687 (2009)

    Article  CAS  PubMed  Google Scholar 

  23. R. Vita, G. Saraceno, F. Trimarchi, S. Benvenga, A novel formulation of l-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations. Endocrine 43, 154–160 (2013)

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have nothing to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mehmet Asik.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Asik, M., Gunes, F., Binnetoglu, E. et al. Decrease in TSH levels after lactose restriction in Hashimoto’s thyroiditis patients with lactose intolerance. Endocrine 46, 279–284 (2014). https://doi.org/10.1007/s12020-013-0065-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-013-0065-1

Keywords

Navigation